Related references
Note: Only part of the references are listed.Topical TLR7 Agonist Imiquimod Can Induce Immune-Mediated Rejection of Skin Metastases in Patients with Breast Cancer
Sylvia Adams et al.
CLINICAL CANCER RESEARCH (2012)
MF59 and Pam3CSK4 Boost Adaptive Responses to Influenza Subunit Vaccine through an IFN Type I-Independent Mechanism of Action
Elena Caproni et al.
JOURNAL OF IMMUNOLOGY (2012)
Immunomodulation by Imiquimod in Patients with High-Risk Primary Melanoma
Rupa Narayan et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
Potent Adjuvanticity of a Pure TLR7-Agonistic Imidazoquinoline Dendrimer
Nikunj M. Shukla et al.
PLOS ONE (2012)
Effect of Adjuvants on Responses to Skin Immunization by Microneedles Coated with Influenza Subunit Vaccine
William C. Weldon et al.
PLOS ONE (2012)
Evaluation of immune responses to a Plasmodium vivax CSP-based recombinant protein vaccine candidate in combination with second-generation adjuvants in mice
Joanne M. Lumsden et al.
VACCINE (2012)
Toward self-adjuvanting subunit vaccines: Model peptide and protein antigens incorporating covalently bound toll-like receptor-7 agonistic imidazoquinolines
Nikunj M. Shukla et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Priming CD8+ T cells with dendritic cells matured using TLR4 and TLR7/8 ligands together enhances generation of CD8+ T cells retaining CD28
Jeffrey S. Pufnock et al.
BLOOD (2011)
Phase I Study Utilizing a Novel Antigen-Presenting Cell-Targeted Vaccine with Toll-like Receptor Stimulation to Induce Immunity to Self-antigens in Cancer Patients
Michael A. Morse et al.
CLINICAL CANCER RESEARCH (2011)
TLR-7 and-8 agonists as vaccine adjuvants
Mark A. Tomai et al.
EXPERT REVIEW OF VACCINES (2011)
Combination adjuvants: the next generation of adjuvants?
George Mutwiri et al.
EXPERT REVIEW OF VACCINES (2011)
Protective T cell immunity in mice following protein-TLR7/8 agonist-conjugate immunization requires aggregation, type I IFN, and multiple DC subsets
Kathrin Kastenmueller et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
TLR ligands induce synergistic interferon-beta and interferon-lambda 1 gene expression in human monocyte-derived dendritic cells
Sanna M. Makela et al.
MOLECULAR IMMUNOLOGY (2011)
Programming the magnitude and persistence of antibody responses with innate immunity
Sudhir Pai Kasturi et al.
NATURE (2011)
The immune responses of HLA-A*0201 restricted SARS-CoV S peptide-specific CD8+ T cells are augmented in varying degrees by CpG ODN, PolyI:C and R848
Kai Zhao et al.
VACCINE (2011)
A TLR2 agonist is a more effective adjuvant for a Chlamydia major outer membrane protein vaccine than ligands to other TLR and NOD receptors
Chunmei Cheng et al.
VACCINE (2011)
Vaccine adjuvant activity of 3M-052: An imidazoquinoline designed for local activity without systemic cytokine induction
Dmitri Smirnov et al.
VACCINE (2011)
Commonly used prophylactic vaccines as an alternative for synthetically produced TLR ligands to mature monocyte-derived dendritic cells
Gerty Schreibelt et al.
BLOOD (2010)
Plasmacytoid dendritic cell-derived type I interferon is crucial for the adjuvant activity of Toll-like receptor 7 agonists
Deepa Rajagopal et al.
BLOOD (2010)
An Intranasally Delivered Toll-Like Receptor 7 Agonist Elicits Robust Systemic and Mucosal Responses to Norwalk Virus-Like Particles
Lissette S. Velasquez et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Vaccine Adjuvants: Putting Innate Immunity to Work
Robert L. Coffman et al.
IMMUNITY (2010)
Protective effects of Sm-p80 in the presence of resiquimod as an adjuvant against challenge infection with Schistosoma mansoni in mice
Gul Ahmad et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2010)
Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8α+ dendritic cells
Lionel Franz Poulin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
The Capacity To Induce Cross-Presentation Dictates the Success of a TLR7 Agonist-Conjugate Vaccine for Eliciting Cellular Immunity
Jason Z. Oh et al.
JOURNAL OF IMMUNOLOGY (2010)
TLR8 agonists stimulate newly recruited monocyte-derived cells into potent APCs that enhance HBsAg immunogenicity
Jun Du et al.
VACCINE (2010)
Topical resiquimod promotes priming of CTL to parenteral antigens
Brent A. Chang et al.
VACCINE (2009)
Intradermal immunization improves protective efficacy of a novel TB vaccine candidate
Susan L. Baldwin et al.
VACCINE (2009)
Recognition of viral single-stranded RNA by Toll-like receptors
Sandra S. Diebold
ADVANCED DRUG DELIVERY REVIEWS (2008)
The antiviral activity of toll-like receptor 7 and 7/8 agonists
Richard L. Miller et al.
DRUG NEWS & PERSPECTIVES (2008)
Immunization with a toll-like receptor 7 and/or 8 agonist vaccine adjuvant increases protective immunity against Leishmania major in BALB/c mice
Wen-Wei Zhang et al.
INFECTION AND IMMUNITY (2008)
Immunization of malignant melanoma patients with full-length NY-ESO-1 protein using TLR7 agonist imiquimod as vaccine adjuvant
Sylvia Adams et al.
JOURNAL OF IMMUNOLOGY (2008)
Plasticity of dendritic cell function in response to prostaglandin E2 (PGE2) and interferon-γ (IFN-γ)
Manfred Lehner et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
Expression and function of Toll-like receptors on dendritic cells and other antigen presenting cells from non-human primates
Chutitorn Ketloy et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2008)
Additive effects of CpG ODN and R-848 as adjuvants on augmenting immune responses to HBsAg vaccination
Rui Ma et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Synthetic imidazoquinolines potently and broadly activate the cellular immune response of patients with cutaneous T-Cell lymphoma:: Synergy with interferon-γ enhances production of interleukin-12
Maria Wysocka et al.
CLINICAL LYMPHOMA & MYELOMA (2007)
Toll-like receptor activation enhances cell-mediated immunity induced by an antibody vaccine targeting human dendritic cells
Venky Ramakrishna et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2007)
Nucleic acid agonists for toll-like receptor 7 are defined by the presence of uridine ribonucleotides
Sandra S. Diebold et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
High-avidity antitumor T-cell generation by toll receptor 8-primed, myeloid-derived dendritic cells is mediated by IL-12 production
Shuwen Xu et al.
SURGERY (2006)
A preliminary evaluation of alternative adjuvants to alum using a range of established and new generation vaccine antigens
M Singh et al.
VACCINE (2006)
Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity
T Querec et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Respiratory syncytial virus induces TLR3 protein and protein kinase R, leading to increased double-stranded RNA responsiveness in airway epithelial cells
DJ Groskreutz et al.
JOURNAL OF IMMUNOLOGY (2006)
Therapeutic potential of Toll-like receptor 9 activation
Arthur M. Krieg
NATURE REVIEWS DRUG DISCOVERY (2006)
TLR agonists as vaccine adjuvants: comparison of CpG ODN and Resiquimod (R-848)
RD Weeratna et al.
VACCINE (2005)
HIV Gag protein conjugated to a toll-like receptor 7/8 agonist improves the magnitude and quality of Th1 and CD8+ T cell responses in nonhuman primates
U Wille-Reece et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Toll-like receptor 3 is induced by and mediates antiviral activity against rhinovirus infection of human bronchial epithelial cells
CA Hewson et al.
JOURNAL OF VIROLOGY (2005)
Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells
G Napolitani et al.
NATURE IMMUNOLOGY (2005)
Triggering of TLR3 by polyI:C in human corneal epithelial cells to induce inflammatory cytokines
M Ueta et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Resiquimod is a modest adjuvant for HIV-1 gag-based genetic immunization in a mouse model
M Otero et al.
VACCINE (2004)
Imiquimod and resiquimod in a mouse model: adjuvants for DNA vaccination by particle-mediated immunotherapeutic delivery
LL Thomsen et al.
VACCINE (2004)
Combined TLR and CD40 triggering induces potent CD8+ T cell expansion with variable dependence on type I IFN
CL Ahonen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Toll-like receptor control of the adaptive immune responses
A Iwasaki et al.
NATURE IMMUNOLOGY (2004)
Shaping of adaptive immune responses to soluble proteins by TLR agonists:: A role for IFN-α/β
V Durand et al.
IMMUNOLOGY AND CELL BIOLOGY (2004)
Endotoxin contamination of ovalbumin suppresses murine immunologic responses and development of airway hyper-reactivity
J Watanabe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Subcellular localization of toll-like receptor 3 in human dendritic cells
M Matsumoto et al.
JOURNAL OF IMMUNOLOGY (2003)
Regulation of dendritic cell function through Toll-like receptors
T Kaisho et al.
CURRENT MOLECULAR MEDICINE (2003)
Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod
SJ Gibson et al.
CELLULAR IMMUNOLOGY (2002)
Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848
M Jurk et al.
NATURE IMMUNOLOGY (2002)
Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling
M Matsumoto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway
H Hemmi et al.
NATURE IMMUNOLOGY (2002)
Toll-like receptors: critical proteins linking innate and acquired immunity
S Akira et al.
NATURE IMMUNOLOGY (2001)
Adjuvant activities of immune response modifier R-848: Comparison with CpG ODN
JP Vasilakos et al.
CELLULAR IMMUNOLOGY (2000)
Advances in immunology: Innate immunity.
R Medzhitov et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
The immune response modifiers imiquimod and R-848 are potent activators of B lymphocytes
MA Tomai et al.
CELLULAR IMMUNOLOGY (2000)
Innate immune recognition: mechanisms and pathways
R Medzhitov et al.
IMMUNOLOGICAL REVIEWS (2000)
The imidazoquinolines, imiquimod and R-848, induce functional, but not phenotypic, maturation of human epidermal Langerhans' cells
RP Burns et al.
CLINICAL IMMUNOLOGY (2000)
Share Paper
